Skip to main content
. 2017 Sep 6;19(3):347–355. doi: 10.5853/jos.2017.00395

Figure 2.

Figure 2.

Distribution of time since last intake of rivaroxaban and measured rivaroxaban plasma levels in patients treated with intravenous thrombolysis (IVT) (●) and those not treated with IVT (○). The rivaroxaban plasma level thresholds for IVT recommended (brocken line) and IVT to-beconsedered (continuous line) are indicated.